Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: An autopsy-based study

Journal of Clinical Microbiology

Volumn 49, Issue 11, 2011, Pages 3783-3787

  De Vlieger, Greet ^a   Lagrou, Katrien ^a   Maertens, Johan ^a   Verbeken, Eric ^a   Meersseman, Wouter ^a   Van Wijngaerden, Eric ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN; PIPERACILLIN PLUS TAZOBACTAM;

ARTICLE; AUTOPSY; BETA 1,3 GLUCAN BLOOD LEVEL; BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; INTENSIVE CARE UNIT; INVASIVE ASPERGILLOSIS; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; REFERENCE VALUE; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYMPTOM;

AUTOPSY; BETA-GLUCANS; BIOLOGICAL MARKERS; CRITICAL ILLNESS; DIAGNOSTIC TESTS, ROUTINE; HOSPITALS; HUMANS; IMMUNOCOMPROMISED HOST; INVASIVE PULMONARY ASPERGILLOSIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SERUM;

EID: 80355126194     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00879-11     Document Type: Article

References (25)

1. Ascioglu, S., et al. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34:7-14. (Pubitemid 33152659)
2. Bulpa, P., A. Dive, and Y. Sibille. 2007. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur. Respir. J. 30:782-800. (Pubitemid 351194841)
3. Caillot, D., et al. 1997. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J. Clin. Oncol. 15:139-147. (Pubitemid 27020567)
4. Cordonnier, C., et al. 2009. Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis. Clin. Microbiol. Infect. 15:81-86.
5. Cornillet, A., et al. 2006. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin. Infect. Dis. 43:577-584. (Pubitemid 44267116)
6. De Pauw, B., et al. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821.
7. Digby, J., et al. 2003. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin. Diagn. Lab Immunol. 10:882-885. (Pubitemid 37129504)
8. Heyland, D., X. Jiang, A. Day, and M. Laverdiere. 2 May 2011, posting date. Serum β-D-glucan of critically ill patients with suspected ventilator-associated pneumonia: preliminary observations. J. Crit. Care doi:10.1016/j.jcrc.2011.01.002.
9. Horvath, J. A., and S. Dummer. 1996. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am. J. Med. 100:171-178. (Pubitemid 26062511)
10. Hossain, M. A., et al. 1997. Comparison between Wako-WB003 and Fungitec G tests for detection of (133)-beta-D-glucan in systemic mycosis. J. Clin. Lab. Anal. 11:73-77. (Pubitemid 27098375)
11. Maertens, J., et al. 2009. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin. Infect. Dis. 49:1688-1693.
12. Marty, F. M., and S. Koo. 2009. Role of (1→3)-beta-D-glucan in the diagnosis of invasive aspergillosis. Med. Mycol. 47:233-240.
13. Meersseman, W., et al. 2008. Galactomannan in bronchoalveolar lavage fluid-a tool for diagnosis aspergillosis in intensive care unit patients. Am. J. Respir. Crit. Care Med. 177:27-34.
14. Meersseman, W., et al. 2004. Invasive aspergillosis in critically ill patients without malignancy. Am. J. Respir. Crit. Care Med. 25:621-625. (Pubitemid 39202203)
15. Mennink-Kersten, M. A., A. Warris, and P. E. Verweij. 2006. 1,3-Beta-Dglucan in patients receiving intravenous amoxicillin-clavulanic acid. N. Engl. J. Med. 354:2834-2835. (Pubitemid 43974215)
16. Metan, G., C. Agkus, H. Buldun, and A. N. Koc. 2010. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections. Infection 38:217-221.
17. Mohr, J., et al. 2011. Prospective survey of (1→3)-β-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting. J. Clin. Microbiol. 49:58-61.
18. Obayashi, T., K. Negishi, T. Suzuki, and N. Funata. 2008. Reappraisal of the serum (1→3)-beta-D-glucan assay for the diagnosis of invasive fungal infections - a study based on autopsy cases from 6 years. Clin. Infect. Dis. 46:1864-1870.
19. Odabasi, Z., et al. 2004. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 39:199-205. (Pubitemid 38971490)
20. Ostrosky-Zeichner, L., et al. 2005. Multicenter clinical evaluation of the (1→3)-beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis. 5:654-659. (Pubitemid 41170353)
21. Pazos, C., J. Ponton, and A. Del Palacio. 2005. Contribution of (1→3)-beta- D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J. Clin. Microbiol. 43:299-305. (Pubitemid 40096315)
22. Pickering, J. W., H. W. Sant, C. A. P. Bowles, W. L. Roberts, and G. L. Woods. 2005. Evaluation of a (1→3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J. Clin. Microbiol. 43:5957-5962. (Pubitemid 43100644)
23. Presterl, E., et al. 2009. Invasive fungal infections and (1,3)-beta-D-glucan serum concentrations in long-term intensive care patients. Int. J. Infect. Dis. 13:707-712.
24. Viscoli, C., et al. 2004. False-positive galactomannan Platelia Aspergillus test result for patients receiving piperacillin-tazobactam. Clin. Infect. Dis. 38:913-916. (Pubitemid 38387245)
25. Von Eiff, M., et al. 1995. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 62:341-347.